Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Avricore Health Inc
V.AVCR
Alternate Symbol(s):
AVCRF
Technology
Diagnostics & Research
Information Technology Services
Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure...
, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:AVCR)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(3)
•••
123600
X
View Profile
View Bullboard History
Comment by
123600
on Sep 04, 2024 9:05am
RE:Q2 FINS Review (3 / 5 stars)
i'd be a little more causious of advertized potential growth
(433)
•••
WolfOakville
X
View Profile
View Bullboard History
Post by
WolfOakville
on Sep 04, 2024 8:00am
Q2 FINS Review (3 / 5 stars)
"The TAM is definitely there if the company can execute, and the simplicity of the model should be one that’s easily scalable. But I don’t think I’m on board quite yet." Full review at link
...more
(0)
•••
CharlesX
X
View Profile
View Bullboard History
Post by
CharlesX
on Aug 31, 2024 5:50pm
Just another vulture company
Profit margins should have been much better on latest earnings but weren't. Management are sucking the funds out of this and leaving little for shareholders. No store growth in many moons. Ask
...more
(3)
•••
123600
X
View Profile
View Bullboard History
Post by
123600
on Aug 31, 2024 3:30pm
AM I THE ONLY ONE
AM I THE ONLY ONE WITH SOME SCEPTICISM ON THE FUTURE RAPID GROWTH OF THIS CO. FIRST I THINK THE SERVICE TO THE PUBLIC IS NEEDED AND INDIVIDUALS SHOULD HAVE THIER MEDIICAL RECORDS ON FILE AND EASILY
...more
(2169)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Aug 30, 2024 2:51pm
Q by Q
Qtr ending Deployed Lease & service Products sold Revenue Gross Profit
...more
(11)
•••
SushiGobbler
X
View Profile
View Bullboard History
Post by
SushiGobbler
on Aug 30, 2024 12:40pm
Huge potential
i hear rumblings of this one on fintwit lately, however nobody has directly mentioned the company as they're likely quietly acquiring, just grabbed a bag today this could be a staple in the
...more
(459)
•••
Benny007
X
View Profile
View Bullboard History
Post by
Benny007
on Aug 15, 2024 10:01am
Ready for a new move?
Looks like AVCR is ready to make another nice move. GLTA, Benny007
(14)
•••
Hawkstein
X
View Profile
View Bullboard History
Comment by
Hawkstein
on May 02, 2024 4:57pm
RE:I'm in!
Good call, load up now as they have just turned to profitability.
(14)
•••
Hawkstein
X
View Profile
View Bullboard History
Comment by
Hawkstein
on May 02, 2024 4:52pm
RE:RE:AVCR Revenue and # of tests done
For Q1 the way you estimate both Lease & service and products sold is a gross over-estimate: - Lease & service: better to use the average store count between the 693 and 776, otherwise it
...more
(44)
•••
snootchybootchy
X
View Profile
View Bullboard History
Post by
snootchybootchy
on May 02, 2024 4:26pm
I'm in!
Been watching this name for some time and decided to jump in today. Seems like really good value here considering the price of the previous financings and how far this company has come since
...more
(2169)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on May 01, 2024 4:11pm
RE:RE:AVCR Revenue and # of tests done
my guess.... Qtr ending Mo sales/site $15 Tests/site/mo Q4 23 462
...more
(2169)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on May 01, 2024 4:05pm
RE:AVCR Revenue and # of tests done
Qtr ending Deployed Lease & service Products sold Revenue Gross Profit
...more
(433)
•••
WolfOakville
X
View Profile
View Bullboard History
Post by
WolfOakville
on May 01, 2024 8:46am
2023 Annual FINS Review (3 / 5 stars)
"When you dig in though I have to wonder how much insiders are interested in retail succeeding." Full Review at: FINS
(2)
•••
Optimiststock
X
View Profile
View Bullboard History
Post by
Optimiststock
on Apr 04, 2024 7:23pm
AVCR Revenue and # of tests done
Signing more sites is great if they actually test patients and bring in revenue. What's the company update on that metric. Love the idea, needs sales and faster execution. IMO
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product